Senate Finance Committee Chair Orrin Hatch joined the mounting effort in Congress to scale back the 340B program and redefine how hospitals use their drug discounts from the program.Original Article
Hatch asks Azar to shift 340B oversight to CMS
You may also like
Insurers Hedge on Trump-Backed Pledge To Improve...
Violence Repeatedly Erupts at Dementia Care Facilities...
Doctors ‘Cringe’ at Possibility of Documenting...
Pregnant Woman’s Roadside Death Triggers Push To...
Tempus to buy cancer test-maker Personalis for $1.5B
Resmed ventilator safety issue linked to 5 serious...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.